Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 0 | $ -19.29M | $ -19.29M |
3/31/2025 | $ 0 | $ -26.67M | $ -26.67M |
12/31/2024 | $ 0 | $ -20.31M | $ -20.31M |
9/30/2024 | $ 129K | $ -35.33M | $ -35.2M |
6/30/2024 | $ 276K | $ -33.88M | $ -33.61M |
3/31/2024 | $ 429K | $ 103.89M | $ 104.31M |
12/31/2023 | $ 580K | $ 70.31M | $ 70.89M |
9/30/2023 | $ 606K | $ 76.64M | $ 77.24M |
6/30/2023 | $ 609K | $ 49.98M | $ 50.58M |
3/31/2023 | $ 602K | $ -85.65M | $ -85.05M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for SCYNEXIS INC is calculated as follows: EBIT [ $ -29M ] + DepAmor [ $ -19K ]
(=) EBITDA [ $ -29.02M ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.24K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.9M |
median | $ 8.92M |
std | $ 167.01M |